2024 Annual Meeting | C151 - Artificial Intelligence (AI) and the Neurologist: New Horizons

Date Wednesday 04/17/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Location Colorado Convention Center | 601

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mark Mintz, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should gain an overall understanding of the types of AI and machine learning, learn about present and potential clinical applications of AI, and be introduced to the benefits and challenges that AI creates for neurologists.

This program is supported in part by an educational grant from Mylan Specialty L.P., a Viatris Company.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Intermediate

Program Tracks Advanced Practice Provider, Artificial Intelligence

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT	Introduction	AI: New Horizons Mark Mintz, MD, FAAN
07:05 AM - 07:15 AM MDT	Speaker	How We Got Here Sankar Bandyopadhyay, MD, FAAN
07:15 AM - 07:30 AM MDT	Discussion	Panel Discussion Mark Mintz, MD, FAAN, Wesley Kerr, MD, PhD, Judith Dexheimer
07:30 AM - 07:40 AM MDT	Speaker	Current Applications Wesley Kerr, MD, PhD
07:40 AM - 08:00 AM MDT	Discussion	Panel Discussion Mark Mintz, MD, FAAN, Braydon Dymm, MD, Wesley Kerr, MD, PhD
08:00 AM - 08:10 AM MDT	Speaker	State of the Art Developments in AI Judith Dexheimer
08:10 AM - 08:30 AM MDT	Discussion	Panel Discussion Daniel Goldenholz, MD, PhD, Sankar Bandyopadhyay, MD, FAAN, Judith Dexheimer
08:30 AM - 08:40 AM MDT	Speaker	The Future Daniel Goldenholz, MD, PhD
08:40 AM - 09:00 AM MDT	Discussion	Panel Discussion Daniel Goldenholz, MD, PhD, Braydon Dymm, MD, Wesley Kerr, MD, PhD

Faculty Disclosures
Mark Mintz, MD, FAAN	The institution of Dr. Mintz has received research support from Curemark. The institution of Dr. Mintz has received research support from Otsuka.
Daniel Goldenholz, MD, PhD	Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuro Event Labs. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for IDR. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova . Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances . Dr. Goldenholz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magic Leap. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACNS. The institution of Dr. Goldenholz has received research support from NIH. The institution of Dr. Goldenholz has received research support from BIDMC. Dr. Goldenholz has a non-compensated relationship as a advisor with Eysz that is relevant to AAN interests or activities. Dr. Goldenholz has a non-compensated relationship as a advisor with Epilepsy AI that is relevant to AAN interests or activities.
Braydon Dymm, MD	Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AvoMD. Dr. Dymm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glass Health.
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. Dr. Kerr has received publishing royalties from a publication relating to health care.
Judith Dexheimer	No disclosure on file